[IgD myeloma]. 1970

F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon
January 1978, Terapevticheskii arkhiv,
F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon
April 1968, British medical journal,
F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon
January 1998, Ryoikibetsu shokogun shirizu,
F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon
October 1976, Orvosi hetilap,
F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon
January 1984, Terapevticheskii arkhiv,
F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon
March 1975, Vnitrni lekarstvi,
F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon
February 1971, Naika. Internal medicine,
F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon
July 1969, German medical monthly,
F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon
March 1969, Naika. Internal medicine,
F Mesnier, and B Hoerni, and A Le Treut, and C Meuge, and J Chauvergne, and G Simon
November 1992, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!